These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
874 related articles for article (PubMed ID: 29762200)
1. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health. Faubion SS; Larkin LC; Stuenkel CA; Bachmann GA; Chism LA; Kagan R; Kaunitz AM; Krychman ML; Parish SJ; Partridge AH; Pinkerton JV; Rowen TS; Shapiro M; Simon JA; Goldfarb SB; Kingsberg SA Menopause; 2018 Jun; 25(6):596-608. PubMed ID: 29762200 [TBL] [Abstract][Full Text] [Related]
2. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. The NAMS 2020 GSM Position Statement Editorial Panel Menopause; 2020 Sep; 27(9):976-992. PubMed ID: 32852449 [TBL] [Abstract][Full Text] [Related]
3. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Portman DJ; Gass ML; J Sex Med; 2014 Dec; 11(12):2865-72. PubMed ID: 25155380 [TBL] [Abstract][Full Text] [Related]
4. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Portman DJ; Gass ML; Menopause; 2014 Oct; 21(10):1063-8. PubMed ID: 25160739 [TBL] [Abstract][Full Text] [Related]
5. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review. Simon JA; Goldstein I; Kim NN; Davis SR; Kellogg-Spadt S; Lowenstein L; Pinkerton JV; Stuenkel CA; Traish AM; Archer DF; Bachmann G; Goldstein AT; Nappi RE; Vignozzi L Menopause; 2018 Jul; 25(7):837-847. PubMed ID: 29870471 [TBL] [Abstract][Full Text] [Related]
6. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause; 2018 Nov; 25(11):1362-1387. PubMed ID: 30358733 [TBL] [Abstract][Full Text] [Related]
7. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Portman DJ; Gass ML; Maturitas; 2014 Nov; 79(3):349-54. PubMed ID: 25179577 [TBL] [Abstract][Full Text] [Related]
8. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. Portman DJ; Gass ML; Climacteric; 2014 Oct; 17(5):557-63. PubMed ID: 25153131 [TBL] [Abstract][Full Text] [Related]
9. The 2017 hormone therapy position statement of The North American Menopause Society. The NAMS 2017 Hormone Therapy Position Statement Advisory Panel Menopause; 2017 Jul; 24(7):728-753. PubMed ID: 28650869 [TBL] [Abstract][Full Text] [Related]
10. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause; 2013 Sep; 20(9):888-902; quiz 903-4. PubMed ID: 23985562 [TBL] [Abstract][Full Text] [Related]
11. Management of genitourinary syndrome of menopause in breast cancer survivors: An update. Lubián López DM World J Clin Oncol; 2022 Feb; 13(2):71-100. PubMed ID: 35316932 [TBL] [Abstract][Full Text] [Related]
12. [Genitourinary menopause syndrome. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines]. Hocké C; Diaz M; Bernard V; Frantz S; Lambert M; Mathieu C; Grellety-Cherbero M Gynecol Obstet Fertil Senol; 2021 May; 49(5):394-413. PubMed ID: 33757926 [TBL] [Abstract][Full Text] [Related]
13. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. North American Menopause Society Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512 [TBL] [Abstract][Full Text] [Related]
14. Treating genitourinary syndrome of menopause in breast cancer survivors: main challenges and promising strategies. Castelo-Branco C; Mension E; Torras I; Cebrecos I; Anglès-Acedo S Climacteric; 2023 Aug; 26(4):296-301. PubMed ID: 36946290 [TBL] [Abstract][Full Text] [Related]
15. Genitourinary syndrome of menopause in breast cancer survivors:Treatments are available. Moreno AC; Sikka SK; Thacker HL Cleve Clin J Med; 2018 Oct; 85(10):760-766. PubMed ID: 30289755 [TBL] [Abstract][Full Text] [Related]
16. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Moral E; Delgado JL; Carmona F; Caballero B; Guillán C; González PM; Suárez-Almarza J; Velasco-Ortega S; Nieto C; Climacteric; 2018 Apr; 21(2):167-173. PubMed ID: 29411644 [TBL] [Abstract][Full Text] [Related]
17. Swiss consensus on the role of DHEA in the management of genitourinary syndrome of menopause. Stute P; Bertschy S; Birkhaeuser M; Bitzer J; Ging A; Raggi A; Steimann S; Stute V Climacteric; 2022 Jun; 25(3):246-256. PubMed ID: 34907824 [TBL] [Abstract][Full Text] [Related]
18. Vaginal estrogen and mammogram results: case series and review of literature on treatment of genitourinary syndrome of menopause (GSM) in breast cancer survivors. Zuo SW; Wu H; Shen W Menopause; 2018 Jul; 25(7):828-836. PubMed ID: 29533365 [TBL] [Abstract][Full Text] [Related]
19. Missing documentation in breast cancer survivors: genitourinary syndrome of menopause. Cook ED; Iglehart EI; Baum G; Schover LL; Newman LL Menopause; 2017 Dec; 24(12):1360-1364. PubMed ID: 28640166 [TBL] [Abstract][Full Text] [Related]
20. The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis. Jha S; Wyld L; Krishnaswamy PH Clin Breast Cancer; 2019 Aug; 19(4):e556-e562. PubMed ID: 31227415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]